Ml. Alvarezbujidos et al., PHARMACOKINETICS OF TRICLABENDAZOLE IN RABBITS, Comparative biochemistry and physiology. C. Comparative pharmacologyand toxicology, 106(3), 1993, pp. 805-808
1. Pharmacokinetic profiles of triclabendazole (TCBZ) following intrav
enous (i.v.) and oral administration of the drug in rabbits were carri
ed out. 2. In normal rabbits, TCBZ was metabolized rapidly to its sulp
hoxide (TCBZ-SO) and sulphone (TCBZ-SO2) derivatives following adminis
tration, with undetectable concentrations of unchanged TCBZ in the pla
sma of the treated animals at any time (detection limit, 10 ng/ml). 3.
The disposition kinetics of this drug in rabbits can be described by
a two-compartment open model. 4. Mean peak concentrations in plasma of
TCBZ-SO and TCBZ-SO2 of 12.41 mu g/ml and 9.5 mu g/ml occurred 7.5 an
d 9.5 hr after oral administration, respectively. 5. Both metabolites
were eliminated slowly from plasma with elimination half-lives of 16.8
6 hr for the sulphoxide and 13 hr for the sulphone. 6. The area under
the plasma concentration versus time curve (AUC) was 240 mg hr/l for t
he sulphoxide, higher than that found for the sulphone, 185g hr/l.